TY - JOUR
T1 - Place of death and the differences in patient quality of death and dying and caregiver burden
AU - Kinoshita, Hiroya
AU - Maeda, Isseki
AU - Morita, Tatsuya
AU - Miyashita, Mitsunori
AU - Yamagishi, Akemi
AU - Shirahige, Yutaka
AU - Takebayashi, Toru
AU - Yamaguchi, Takuhiro
AU - Igarashi, Ayumi
AU - Eguchi, Kenji
N1 - Publisher Copyright:
© 2014 by American Society of Clinical Oncology.
PY - 2015/2/1
Y1 - 2015/2/1
N2 - Purpose To explore the associations between place of death and quality of death and dying and caregiver burden in terminally ill patients with cancer and their families. Methods Two bereavement surveys were conducted in October 2008 and October 2011. A total of 2,247 family caregivers of patients with cancer who were deceased responded to the mail surveys (response rate, 67%). Family members reported patient quality of death and dying and caregiver burden by using the Good Death Inventory and Caregiving Consequences Inventory. Results Patient quality of death and dying was significantly higher at home relative to other places of dying after adjustment for patient and/or family characteristics (adjusted means): 5.0 (95% CI, 4.9 to 5.2) for home, 4.6 (95% CI, 4.5 to 4.7) for palliative care units, and 4.3 (95% CI, 4.2 to 4.4) for hospitals. For all combinations, pairwise P < .001; the size of the difference between home and hospital was moderate (Hedges' g, 0.45). Home was superior to palliative care units or hospitals with respect to " dying in a favorite place," " good relationships with medical staff," " good relationships with family, " and " maintaining hope and pleasure " ( P < .001 for all combinations of home v palliative care units and home v hospitals). Home death was significantly associated with a lower overall (P = .03) and financial caregiver burden ( P = .004) relative to hospital death. Conclusion Dying at home may contribute to achieving good death in terminally ill patients with cancer without causing remarkably increased caregiver burden. Place of death should be regarded as an essential goal in end-of-life care.
AB - Purpose To explore the associations between place of death and quality of death and dying and caregiver burden in terminally ill patients with cancer and their families. Methods Two bereavement surveys were conducted in October 2008 and October 2011. A total of 2,247 family caregivers of patients with cancer who were deceased responded to the mail surveys (response rate, 67%). Family members reported patient quality of death and dying and caregiver burden by using the Good Death Inventory and Caregiving Consequences Inventory. Results Patient quality of death and dying was significantly higher at home relative to other places of dying after adjustment for patient and/or family characteristics (adjusted means): 5.0 (95% CI, 4.9 to 5.2) for home, 4.6 (95% CI, 4.5 to 4.7) for palliative care units, and 4.3 (95% CI, 4.2 to 4.4) for hospitals. For all combinations, pairwise P < .001; the size of the difference between home and hospital was moderate (Hedges' g, 0.45). Home was superior to palliative care units or hospitals with respect to " dying in a favorite place," " good relationships with medical staff," " good relationships with family, " and " maintaining hope and pleasure " ( P < .001 for all combinations of home v palliative care units and home v hospitals). Home death was significantly associated with a lower overall (P = .03) and financial caregiver burden ( P = .004) relative to hospital death. Conclusion Dying at home may contribute to achieving good death in terminally ill patients with cancer without causing remarkably increased caregiver burden. Place of death should be regarded as an essential goal in end-of-life care.
UR - http://www.scopus.com/inward/record.url?scp=84921920558&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84921920558&partnerID=8YFLogxK
U2 - 10.1200/JCO.2014.55.7355
DO - 10.1200/JCO.2014.55.7355
M3 - Article
C2 - 25534381
AN - SCOPUS:84921920558
SN - 0732-183X
VL - 33
SP - 357
EP - 363
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
IS - 4
ER -